← FDA Drug Approvals (Drugs@FDA)

LETAIRIS

NDA · New Drug Application · Sponsor: GILEAD · Approved 2007-06-15

Drug application

FDA Application #

NDA022081

Application type

New Drug Application

Brand name

LETAIRIS

Generic name

AMBRISENTAN

Active ingredients

AMBRISENTAN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

GILEAD

Manufacturer

Gilead Sciences, Inc.

First approval

2007-06-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown